Dr. John Cush RheumNow
3 years 11 months ago
Best of #ACR22 in PsA: Day Three
Dr. Rachel Tate ( @uptoTate) discusses the best PsA content presented on day three (Monday) at ACR22 Convergence in Philadelphia, PA.
https://t.co/NkdaXAMoZE https://t.co/aPnrkYXehz
Familial Mediterranean fever (FMF) is an inherited autoinflammatory disease characterized by recurrent attacks of fever and acute inflammation of the membranes lining the abdomen, joints and lungs. These attacks are often short-lasting, around 1-3 days. It is important to recognise these presenting symptoms so that appropriate investigations and management can be implemented to our patients.
Rheumatic conditions such as SLE and RA exhibit female predominance. In contrast, increasing evidence suggests that gender differences occur in axial spondyloarthritis in terms of time to diagnosis, clinical manifestations, treatment outcomes and quality of life. The exact mechanisms are still poorly understood.
Dr. John Cush RheumNow
3 years 11 months ago
Can Neural Networks Answer Diagnostic Dilemmas in Rheumatology?
Presented at #ACR22, investigators wanted to establish whether neural networks can distinguish seropositive RA+, RA-, and PsA using hand MRI data based on structural inflammation patterns.
https://t.co/X2zceiAQ4J https://t.co/J0VUwlVMze
Dr. John Cush RheumNow
3 years 11 months ago
PsA Cycling or Switching MOAs
Dr. Tate ( @uptoTate) interviews Dr. Alexis Ogdie ( @AlexisO) at #ACR22 on Abstract 1600: The Impact of Second-Line Therapeutic on Disease Control After Discontinuation of First Line TNF Inhibitor in Patients with PsA
https://t.co/S83Wbpbd4V https://t.co/B1gTmMAzc1
Dr. John Cush RheumNow
3 years 11 months ago
Gender in AxSpa
Dr. Peter Nash ( @drpnash) weighs in at #ACR22.
https://t.co/Utkg4Yltif https://t.co/IvZNe9BQHr
Dr. John Cush RheumNow
3 years 11 months ago
Lupus, Sex and STDs
Dr. Kathryn Dao discusses abstract 0939 presented at #ACR22.
https://t.co/4VyRihrpa8 https://t.co/hqsfWeUQQo
Dr. John Cush RheumNow
3 years 11 months ago
Frailty in Vasculitis
Dr. Patricia Harkins ( @DrTrishHarkins) sits down with Professor Sebastian Sattui to discuss Abstract 0444, Prevalence of Frailty and Associated Factors in Patients with Vasculitis, being presented on Saturday at #ACR22.
https://t.co/0Gd1cHNVlg https://t.co/blS2XvHIgS
Dr. John Cush RheumNow
3 years 11 months ago
Do biologics help taper steroids in Adult Still’s Disease?
A Japanese large scale claims data study presented at #ACR22 (abstract#0826) was able to collect 5-year data to study the treatment patterns in Still’s.
https://t.co/S0HMfWuUai https://t.co/ZKV0aP900w
Dr. John Cush RheumNow
3 years 11 months ago
Anifrolumab shows long-term promise in patients with lupus
Researchers report positive results from the first placebo-controlled long-term trial of anifrolumab—a human monoclonal antibody that targets the type I IFN receptor—in patients with lupus.
https://t.co/sYzLMgLzqy https://t.co/fdmhYONI3G
Dr. John Cush RheumNow
3 years 11 months ago
Sputum anti-CCP the new diagnostic test in at-risk RA?'
Dr. Aurelie Najm ( @AurelieRheumo) discusses abstract 0533 at #ACR22.
https://t.co/DNKVmPjmh9 https://t.co/b5x26PzzS5

